• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌的粪便蛋白质标志物。

Fecal protein markers of colorectal cancer.

作者信息

Dubrow R, Yannielli L

机构信息

Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut.

出版信息

Am J Gastroenterol. 1992 Jul;87(7):854-8.

PMID:1615938
Abstract

To identify fecal proteins that might prove useful in the early detection of colorectal cancer, we used sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and protein immunoblotting to compare the fecal protein patterns of stool supernatants from 10 patients with colorectal cancer with those of 12 controls. SDS-PAGE followed by Coomassie blue staining revealed two heavily stained bands in the majority of cancer stools that were not present in control stools. These bands proved to be human hemoglobin and human albumin by protein immunoblotting. No other consistent differences between the cancer and control stools were observed on the stained gels. The stool supernatants were probed for several other blood proteins by protein immunoblotting. Carbonic anhydrases I and II were more abundant in the cancer stools; alpha 1-antitrypsin appeared equally in cancer and control stools. Further work is needed to determine whether measurement of fecal carbonic anhydrase can be useful for early detection of colorectal cancer.

摘要

为了鉴定可能对结直肠癌早期检测有用的粪便蛋白质,我们使用十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)和蛋白质免疫印迹法,比较了10例结直肠癌患者粪便上清液与12例对照者粪便上清液的蛋白质模式。SDS-PAGE后用考马斯亮蓝染色显示,大多数癌性粪便中有两条染色较深的条带,而对照粪便中不存在。通过蛋白质免疫印迹法证实这些条带为人血红蛋白和人白蛋白。在染色凝胶上未观察到癌性粪便与对照粪便之间的其他一致差异。通过蛋白质免疫印迹法检测粪便上清液中的其他几种血液蛋白质。碳酸酐酶I和II在癌性粪便中含量更高;α1-抗胰蛋白酶在癌性粪便和对照粪便中含量相当。需要进一步开展工作以确定检测粪便碳酸酐酶是否有助于结直肠癌的早期检测。

相似文献

1
Fecal protein markers of colorectal cancer.结直肠癌的粪便蛋白质标志物。
Am J Gastroenterol. 1992 Jul;87(7):854-8.
2
Fecal lysozyme: an unreliable marker for colorectal cancer.粪便溶菌酶:一种不可靠的结直肠癌标志物。
Am J Gastroenterol. 1992 May;87(5):617-21.
3
Testing of multiple samples increases the sensitivity of stool decay-accelerating factor test for the detection of colorectal cancer.对多个样本进行检测可提高粪便衰变加速因子检测在结直肠癌检测中的灵敏度。
Am J Gastroenterol. 2003 Nov;98(11):2550-5. doi: 10.1111/j.1572-0241.2003.08672.x.
4
Evaluation of calgranulin B in stools from the patients with colorectal cancer.结直肠癌患者粪便中钙粒蛋白B的评估。
Dis Colon Rectum. 2008 Nov;51(11):1703-9. doi: 10.1007/s10350-008-9381-6. Epub 2008 Jun 27.
5
Measurement of fecal pyruvate kinase type M2 (tumor M2-PK) concentrations in patients with gastric cancer, colorectal cancer, colorectal adenomas and controls.胃癌、结直肠癌、结直肠腺瘤患者及对照组粪便中丙酮酸激酶M2型(肿瘤M2-PK)浓度的测定。
Anticancer Res. 2003 Mar-Apr;23(2A):851-3.
6
The potential role of fecal carbonic anhydrase II in screening for colorectal cancer.
Am Surg. 1997 Mar;63(3):243-6; discussion 246-7.
7
Improved diagnosis of colorectal cancer using a combination of fecal occult blood and novel fecal protein markers.结合粪便潜血和新型粪便蛋白质标志物改善结直肠癌的诊断
Clin Gastroenterol Hepatol. 2008 Oct;6(10):1122-8. doi: 10.1016/j.cgh.2008.04.021.
8
N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.N-Myc下游调控基因4(NDRG4):一种结直肠癌的候选抑癌基因和潜在生物标志物。
J Natl Cancer Inst. 2009 Jul 1;101(13):916-27. doi: 10.1093/jnci/djp131. Epub 2009 Jun 17.
9
[Detection of protein p53 in the stool of patients with colorectal cancer].[结直肠癌患者粪便中p53蛋白的检测]
Gastroenterol Clin Biol. 1997;21(10):754-9.
10
Gastrointestinal tract cancer screening using fecal carcinoembryonic antigen.使用粪便癌胚抗原进行胃肠道癌筛查。
Ann Clin Lab Sci. 2003 Winter;33(1):32-8.